Mangalam Drugs and Organics Ltd has disclosed a default on its loan obligations to Bank of Maharashtra and Bank of Baroda, with overdue dues aggregating more than ₹ 15.57 crore, according to a regulatory filing on Thursday.
The pharmaceutical company said it was making the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed entities to report defaults on debt obligations exceeding 30 days.
As of July 15, 2026, the company had an overdue amount of ₹9.51 crore on its cash credit account with Bank of Maharashtra, where the default commenced on October 17, 2025. It also reported overdue dues of ₹6.06 crore to Bank of Baroda, with the default dating back to October 20, 2025.
Mangalam Drugs said it is making arrangements to clear the overdue amounts “as soon as possible.”
